Inventiva S.A. Inventiva S.A.

Inventiva S.A.

IVA

Rang în acțiuni #10277
Inventiva S.A. is a biopharmaceutical firm currently in the clinical... Inventiva S.A. is a biopharmaceutical firm currently in the clinical development phase, specializing in creating orally administered small molecule treatments for conditions such as non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and various other ailments. Their primary drug candidate, Lanifibranor, has successfully concluded Phase IIb clinical trials for the management of NASH. Furthermore, the company is advancing Odiparcil, a compound that has finished Phase IIa clinical testing specifically for treating the MPS VI subtype. Beyond these, Inventiva maintains a development pipeline featuring several early-stage projects targeting oncology and other medical conditions. Strategic partnerships are in place with AbbVie to address autoimmune diseases, and with Boehringer Ingelheim International GmbH for innovating therapies for idiopathic pulmonary fibrosis. Established in 2011, Inventiva S.A. operates from its headquarters in Daix, France.
Preț acțiune
$3.48
Ultima sincronizare: 2026-10-20
Capitalizare de piață
$820.97M
Schimbare (1 zi)
8.32%
Schimbare (1 an)
-8.38%
Țară
FR
Tranzacționează Inventiva S.A. (IVA)

Categorie

Healthcare
Istoricul spliturilor pentru Inventiva S.A. (IVA)
Acțiunea Inventiva S.A. (simbol: IVA) a trecut printr-un total de 0 splituri.
Cel mai recent split a avut loc pe Oct 21, 2026.
O acțiune IVA cumpărată înainte de Oct 21, 2026 este echivalentă astăzi cu 0 acțiuni IVA.
Listă splituri acțiuni
An Split Multiplu Multiplu cumulativ
Nu sunt suficiente date pentru perioada selectată.
Splituri pentru companii similare sau competitori
Companie Număr total de splituri Multiplu cumulativ Țara
1 x2
US
0 -
US
1 x3
AU
0 -
CH
0 -
NL